Paris
Capstone’s Paris office provides investor and corporate clients with on the ground insights on European regulatory issues and beyond.
15 Rue Feydeau, Room 309
75002 Paris, France
Our Latest Insights
From Siloed to Seamless: The New Policy Backdrop of Health Tech Winners and Losers
August 18, 2025 By Eric Schiavone and Grace Totman, Capstone Healthcare Analysts It seems like every few years, there is a burst of excitement about healthcare technology. From AI replacing doctors, to full lab tests with a single drop of blood, to telemedicine-first...
US-India Relations Hit a Roadblock (Again)
August 6, 2025 By Alexander Slater, Managing Director American investors and companies that are looking at India as their next big opportunity or an alternative supply chain node to China, as well as Indian companies seeking to enter or expand their footprint in the...
The 340B Dilemma: The Power of Vague Law
July 21, 2025 By Angela Lamari, Capstone Healthcare analyst At only eight and a half pages of statute, the federal 340B drug pricing program is a clear example of how industry speaks when the law is silent. The program itself is fairly simple—in 1992, the government...
